Teaima, M.H.;                     Helal, D.A.;                     Alsofany, J.M.;                     El-Nabarawi, M.A.;                     Yasser, M.    
        Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics 2022, 14, 2405.
    https://doi.org/10.3390/pharmaceutics14112405
    AMA Style
    
                                Teaima MH,                                 Helal DA,                                 Alsofany JM,                                 El-Nabarawi MA,                                 Yasser M.        
                Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics. 2022; 14(11):2405.
        https://doi.org/10.3390/pharmaceutics14112405
    
    Chicago/Turabian Style
    
                                Teaima, Mahmoud H.,                                 Doaa A. Helal,                                 Jihad M. Alsofany,                                 Mohamed A. El-Nabarawi,                                 and Mohamed Yasser.        
                2022. "Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal" Pharmaceutics 14, no. 11: 2405.
        https://doi.org/10.3390/pharmaceutics14112405
    
    APA Style
    
                                Teaima, M. H.,                                 Helal, D. A.,                                 Alsofany, J. M.,                                 El-Nabarawi, M. A.,                                 & Yasser, M.        
        
        (2022). Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics, 14(11), 2405.
        https://doi.org/10.3390/pharmaceutics14112405